TAYLOR CLIVE R 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Sep 25, 2003
Insider Transaction Report
Form 4
TAYLOR CLIVE R
Director
Transactions
- Exercise/Conversion
Common Stock
2003-09-23$0.34/sh+36,800$12,512→ 55,800 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-09-23$2.35/sh−36,800$86,480→ 1,722,000 totalExercise: $0.34From: 2001-12-22Exp: 2009-12-22→ Common Stock (36,800 underlying) - Sale
Common Stock
2003-09-23$2.35/sh−36,800$86,480→ 19,000 total